APA (7th ed.) Citation

Prabhash, K., Deshmukh, C., Malhotra, H., Sharma, A., Jain, M., Dhamne, N., . . . Aiwale, A. Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial. American Society of Clinical Oncology.

Chicago Style (17th ed.) Citation

Prabhash, Kumar, et al. Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial. American Society of Clinical Oncology.

MLA (9th ed.) Citation

Prabhash, Kumar, et al. Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial. American Society of Clinical Oncology.